why Esperion Therapeutics Inc [ESPR] is a Good Choice for Investors After New Price Target of $7.13
Esperion Therapeutics Inc [NASDAQ: ESPR] traded at a high on Wednesday, posting a 2.33 gain after which it closed the day’ session at $2.20. The results of the trading session contributed to over 5882037 shares changing hands. Over the past one week, the price volatility